Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
China flag China · Delayed Price · Currency is CNY
57.31
+0.75 (1.33%)
At close: Feb 13, 2026

SHA:688580 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
429.11395.34455.44319.67428.73376.63
Other Revenue
4.724.726.781.951.311.74
433.83400.06462.22321.62430.04378.37
Revenue Growth (YoY)
2.75%-13.45%43.72%-25.21%13.66%18.66%
Cost of Revenue
147.66138.26149.1688.52108.4599.76
Gross Profit
286.17261.8313.06233.1321.59278.6
Selling, General & Admin
135.06138.92152.48129.71116.08105.82
Research & Development
42.450.6157.6543.7363.5234.29
Other Operating Expenses
-7.88-11.64-14.08-7.67-6.97-4.12
Operating Expenses
171.03179.33198.31166.29173.52136.76
Operating Income
115.1482.48114.7566.82148.07141.84
Interest Expense
-1.39-1.31-1.32-0.33-0.18-0.41
Interest & Investment Income
16.9121.1129.935.2937.3519.85
Other Non Operating Income (Expenses)
0.020.140.06-0.2-0.04-0.05
EBT Excluding Unusual Items
130.68102.42143.39101.57185.2161.23
Gain (Loss) on Sale of Investments
2.422.42-0.96---
Gain (Loss) on Sale of Assets
-0.01-0.01-0.01-0.01-0.010.04
Asset Writedown
-0.12-----
Other Unusual Items
8.718.457.64.2912.194.81
Pretax Income
141.68113.28150.01105.84197.38166.08
Income Tax Expense
15.7311.3113.7512.0119.8422.95
Earnings From Continuing Operations
125.95101.97136.2693.83177.54143.13
Minority Interest in Earnings
----0.280.52
Net Income
125.95101.97136.2693.83177.81143.66
Net Income to Common
125.95101.97136.2693.83177.81143.66
Net Income Growth
11.71%-25.16%45.23%-47.23%23.77%44.06%
Shares Outstanding (Basic)
969596969682
Shares Outstanding (Diluted)
969596969682
Shares Change (YoY)
-0.07%-0.29%0.05%-0.31%17.41%13.89%
EPS (Basic)
1.321.071.430.981.861.76
EPS (Diluted)
1.321.071.420.981.851.76
EPS Growth
11.80%-24.95%45.16%-47.07%5.42%26.50%
Free Cash Flow
57.445.210.72-9.4570.02109.11
Free Cash Flow Per Share
0.600.060.01-0.100.731.33
Dividend Per Share
0.8000.8001.0760.4910.9300.751
Dividend Growth
-25.62%-25.62%119.02%-47.19%23.87%-
Gross Margin
65.96%65.44%67.73%72.48%74.78%73.63%
Operating Margin
26.54%20.62%24.82%20.77%34.43%37.49%
Profit Margin
29.03%25.49%29.48%29.17%41.35%37.97%
Free Cash Flow Margin
13.24%1.30%0.15%-2.94%16.28%28.84%
EBITDA
136.09102.56133.6982.77157.96150.63
EBITDA Margin
31.37%25.64%28.92%25.74%36.73%39.81%
D&A For EBITDA
20.9420.0918.9515.959.898.79
EBIT
115.1482.48114.7566.82148.07141.84
EBIT Margin
26.54%20.62%24.82%20.77%34.43%37.49%
Effective Tax Rate
11.10%9.98%9.17%11.35%10.05%13.82%
Revenue as Reported
433.83400.06462.22321.62430.04378.37
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.